DÄ internationalArchiveReferences
References

Review article

Lung Transplantation

Dtsch Arztebl Int 2014; 111(7): 107-16. DOI: 10.3238/arztebl.2014.0107

Hartert, M; Senbaklavaci, Ö; Gohrbandt, B; Fischer, B M; Buhl, R; Vahl, C

1.Kugler C, Gottlieb J, Warnecke G, et al.: Health-related quality of life after solid organ transplantation: A prospective, multiorgan cohort study. Transplantation 2013; 96: 316–23. CrossRef MEDLINE
2.Singer JP, Singer LG: Quality of life in lung transplantation. Semin Respir Crit Care Med 2013; 34: 421–30. CrossRef MEDLINE
3.Cooper JD, Pearson FG, Patterson GA, et al.: Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg 1987; 93: 173–81. MEDLINE
4.Patterson GA, Cooper JD, Goldman B, et al.: Technique of successful clinical double-lung transplantation. Ann Thorac Surg 1988; 45: 626–33. CrossRef MEDLINE
5.Puri V, Patterson GA: Adult lung transplantation: technical considerations. Semin Thorac Cardiovasc Surg 2008; 20: 152–64. CrossRef MEDLINE
6.Yusen RD, Christie JD, Edwards LB, et al.: International Society for Heart and Lung Transplantation. The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report-2013; focus theme: age. J Heart Lung Transplant 2013; 32: 965–78. CrossRef MEDLINE
7.Deutsche Stiftung Organtransplantation (DSO). Organspende und Transplantation in Deutschland. Jahresbericht 2012. www.dso.de/uploads/tx_dsodl/DSO_JB12_d_Web.pdf (last accessed on 13 January 2014).
8.Shah PD, Orens JB: Guidelines for the selection of lung-transplant candidates. Curr Opin Organ Transplant 2012; 17: 467–73. CrossRef MEDLINE
9.Thabut G, Fournier M: Assessing survival benefits from lung transplantation. Rev Mal Respir 2011; 28: 1–6. CrossRef MEDLINE
10.Machuca TN, Camargo SM, Schio SM, et al.: Lung transplantation for patients older than 65 years: is it a feasible option? Transplant Proc 2011; 43: 233–5. CrossRef MEDLINE
11.Hook JL, Lederer DJ: Selecting lung transplant candidates: where do current guidelines fall short? Expert Rev Respir Med 2012; 6: 51–61. CrossRef MEDLINE PubMed Central
12.Kreider M, Hadjiliadis D, Kotloff RM: Candidate selection, timing of listing, and choice of procedure for lung transplantation. Clin Chest Med 2011; 32: 199–211. CrossRef MEDLINE
13.Beaty CA, George TJ, Kilic A, Conte JV, Shah AS: Pre-transplant malignancy: an analysis of outcomes after thoracic organ transplantation. J Heart Lung Transplant 2013; 32: 202–11. CrossRef MEDLINE
14.Kanaan R: Indications and contraindications to lung transplant: patient selection. Rev Pneumol Clin 2010; 67: 5–14. CrossRef MEDLINE
15.Smits JM, Vanhaecke J, Haverich A, et al.: Waiting for a thoracic transplant in Eurotransplant. Transpl Int 2006; 19: 54–66. CrossRef MEDLINE
16. Orens JB, Estenne M, Arcasoy S, et al.: International guidelines for the selection of lung transplant candidates: 2006 update – a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745–55. CrossRef MEDLINE
17.Li M, Mathur S, Chowdhury NA, Helm D, Singer LG: Pulmonary rehabilitation in lung transplant candidates. J Heart Lung Transplant 2013; 32: 626–32. CrossRef MEDLINE
18.Bartels MN, Armstrong HF, Gerardo RE, et al.: Evaluation of pulmonary function and exercise performance by cardiopulmonary exercise testing before and after lung transplantation. Chest 2011; 140: 1604–11. CrossRef MEDLINE
19. Strueber M, Reichenspurner H: Die Einführung des Lungenallokations-Scores für die Lungentransplantation in Deutschland. Dtsch Arztebl 2011; 108: A-2424. VOLLTEXT
20.Yusen RD: Technology and outcomes assessment in lung transplantation. Proc Am Thorac Soc 2009; 6: 128–36. CrossRef MEDLINE PubMed Central
21. Gottlieb J: Update on lung transplantation. Ther Adv Respir Dis 2008; 2: 237–47. CrossRef MEDLINE
22.Penninga L, Penninga EI, Møller CH, Iversen M, Steinbrüchel DA, Gluud C: Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev 2013; 31: 5. MEDLINE
23.Floreth T, Bhorade SM: Current trends in immunosuppression for lung transplantation. Semin Respir Crit Care Med 2010; 31: 172–8. CrossRef MEDLINE
24.de Pablo A, Santos F, Solé A, et al.: Recommendations on the use of everolimus in lung transplantation. Transplant Rev 2013; 27: 9–16. CrossRef MEDLINE
25.Swarup R, Allenspach LL, Nemeh HW, Stagner LD, Betensley AD: Timing of basiliximab induction and development of acute rejection in lung transplant patients. J Heart Lung Transplant 2011; 30: 1228–35. CrossRef MEDLINE
26.Todd JL, Palmer SM: Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest 2011; 140: 502–8. CrossRef MEDLINE
27.Uhlin M, Mattsson J, Maeurer M: Update on viral infections in lung transplantation. Curr Opin Pulm Med 2012; 18: 264–70. CrossRef MEDLINE
28.Carmona EM, Limper AH: Update on the diagnosis and treatment of pneumocystis pneumonia. Ther Adv Respir Dis 2011; 5: 41–59. CrossRef MEDLINE
29.Schuurmans MM, Benden C, Inci I: Practical approach to early postoperative management of lung transplant recipients. Swiss Med Wkly 2013; 143: w13773. CrossRef
30.Vivodtzev I, Pison C, Guerrero K, et al.: Benefits of home-based endurance training in lung transplant recipients. Respir Physiol Neurobiol 2011; 177: 189–98. CrossRef MEDLINE
31.Suzuki Y, Cantu E, Christie JD: Primary graft dysfunction. Semin Respir Crit Care Med 2013; 34: 305–19. CrossRef MEDLINE
32.Dilling DF, Glanville AR: Advances in lung transplantation: the year in review. Heart Lung Transplant 2011; 30: 247–51. CrossRef MEDLINE
33.Glanville AR: The role of surveillance bronchoscopy post-lung transplantation. Semin Respir Crit Care Med 2013; 34: 414–20. CrossRef MEDLINE
34.Sims KD, Blumberg EA: Common infections in the lung transplant recipient. Clin Chest Med 2011; 32: 327–41. CrossRef MEDLINE
35.Porhownik NR: Airway complications post lung transplantation. Curr Opin Pulm Med 2013; 19: 174–80. CrossRef MEDLINE
36.Belli EV, Landolfo K, Keller C, Thomas M, Odell J: Lung cancer following lung transplant: Single institution 10 year experience. Lung Cancer 2013; 81: 451–4. CrossRef MEDLINE
37.Muchtar E, Kramer MR, Vidal L, et al.: Posttransplantation lymphoproliferative disorder in lung transplant recipients: A 15-year single institution experience. Transplantation 2013; 96: 657–63. CrossRef MEDLINE
38.Robbins HY, Arcasoy SM: Malignancies following lung transplantation. Clin Chest Med 2011; 32: 343–55. CrossRef MEDLINE
39.Li M, Mathur S, Chowdhury NA, Helm D, Singer LG: Pulmonary rehabilitation in lung transplant candidates. J Heart Lung Transplant 2013; 32: 626–32. CrossRef MEDLINE
40. Shah RJ, Kotloff RM: Lung transplantation for obstructive lung diseases. Semin Respir Crit Care Med 2013; 34: 288–96. CrossRef MEDLINE
e1.Singer JP, Chen J, Blanc PD, Leard LE, Kukreja J, Chen H: A thematic analysis of quality of life in lung transplant: the existing evidence and implications for future directions. Am J Transplant 2013; 13: 839–50. CrossRef MEDLINE
e2.Boffini M, Ranieri VM, Rinaldi M: Lung transplantation: is it still an experimental procedure? Curr Opin Crit Care 2010; 16: 53–61. CrossRef MEDLINE
e3.Knoop C, Estenne M: Disease-specific approach to lung transplantation. Curr Opin Organ Transplant 2009; 14: 466–70. CrossRef MEDLINE
e4.Date H: Update on living-donor lobar lung transplantation. Curr Opin Organ Transplant 2011; 16: 453–7. CrossRef MEDLINE
e5.Panocchia N, Bossola M, Silvestri P, et al.: Ethical evaluation of risks related to living donor transplantation programs. Transplant Proc 2013; 45: 2601–3. CrossRef MEDLINE
e6.Christie JD, Edwards LB, Kucheryavaya AY, et al.: The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31: 1073–86. CrossRef MEDLINE
e7.Kreider M, Kotloff RM: Selection of candidates for lung transplantation. Proc Am Thorac Soc 2009; 6: 20–7. CrossRef MEDLINE
e8.Todd JL, Palmer SM: Lung transplantation in advanced COPD: is it worth it? Semin Respir Crit Care Med 2010; 31: 365–72. CrossRef MEDLINE PubMed Central
e9.Shah RJ, Kotloff RM: Lung transplantation for obstructive lung diseases. Semin Respir Crit Care Med 2013; 34: 288–96. CrossRef MEDLINE
e10.Eskander A, Waddell TK, Faughnan ME, Chowdhury N, Singer LG: BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation. J Heart Lung Transplant 2011; 30: 1334–41. CrossRef MEDLINE
e11.Gottlieb J: Lung transplantation for interstitial lung diseases and pulmonary hypertension. Semin Respir Crit Care Med 2013; 34: 281–7. CrossRef MEDLINE
e12.Corris PA: Lung transplantation for cystic fibrosis and bronchiectasis. Semin Respir Crit Care Med 2013; 34: 297–304. CrossRef MEDLINE
e13.Rosenblatt RL: Lung transplantation in cystic fibrosis. Respir Care 2009; 54: 777–87. CrossRef MEDLINE
e14.Lordan JL, Corris PA: Pulmonary arterial hypertension and lung transplantation. Expert Rev Respir Med 2011; 5: 441–54. CrossRef MEDLINE
e15.Tomaszek SC, Fibla JJ, Dierkhising RA, et al.: Outcome of lung transplantation in elderly recipients. Eur J Cardiothorac Surg 2011; 39: 726–31. CrossRef MEDLINE
e16.Thabut G, Ravaud P, Christie JD: Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 1156–63. CrossRef MEDLINE
e17.Fischer S, Meyer K, Tessmann R, et al.: Outcome following single vs bilateral lung transplantation in recipients 60 years of age and older. Transplant Proc 2005; 37: 1369–70. CrossRef MEDLINE
e18.Dierich M, Fuehner T, Welte T, Simon A, Gottlieb J: Lung transplantation. Indications, long-term results and special impact of follow-up care. Internist 2009; 50: 561–71. CrossRef MEDLINE
e19.Jackson SH, Weale MR, Weale RA: Biological age – what is it and can it be measured? Arch Gerontol Geriatr 2003; 36: 103–15. CrossRef MEDLINE
e20.Reynaud-Gaubert M, Boniface S, Métivier AC, Kessler R: When should patients be referred by the physician to the lung transplant team? Patient selection, indications, timing of referral and preparation for lung transplantation. Rev Mal Respir 2008; 25: 1251–9. MEDLINE
e21.Gottlieb J, Welte T, Höper MM, Strüber M, Niedermeyer J: Lung transplantation. Possibilities and limitations. Internist 2004; 45: 1246–59. CrossRef MEDLINE
e22.Florian J, Rubin A, Mattiello R, da Fontoura FF, Camargo de J, Teixeira PJ: Impact of pulmonary rehabilitation on quality of life and functional capacity in patients on waiting lists for lung transplantation. J Bras Pneumol 2013; 39: 349–56. CrossRef MEDLINE
e23.Wickerson L, Mathur S, Helm D, Singer L, Brooks D: Physical activity profile of lung transplant candidates with interstitial lung disease. J Cardiopulm Rehabil Prev 2013; 33: 106–12. CrossRef MEDLINE
e24.Langer D, Cebrià i Iranzo MA, Burtin C, et al.: Determinants of physical activity in daily life in candidates for lung transplantation. Respir Med 2012; 106: 747–54. CrossRef MEDLINE
e25.Mathur S, Hornblower E, Levy RD: Exercise training before and after lung transplantation. Phys Sportsmed 2009; 37: 78–87. CrossRef MEDLINE
e26.de Pablo A, Juarros L, Jodra S, et al.: Lung Transplantation Unit. Analysis of patients referred to a lung transplantation unit. Transplant Proc 2013; 45: 2351–6. CrossRef MEDLINE
e27.Toyoda Y, Bhama JK, Shigemura N, et al.: Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation. J Thorac Cardiovasc Surg 2013; 145: 1065–70. CrossRef MEDLINE
e28.Hoopes CW, Kukreja J, Golden J, Davenport DL, Diaz-Guzman E, Zwischenberger JB: Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg 2013; 145: 862–7. CrossRef MEDLINE
e29.Orens JB, Garrity ER Jr: General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc 2009; 6: 13–9. CrossRef MEDLINE
e30.Nakamura Y, Tanaka K, Shigematsu R, Nakagaichi M, Inoue M, Homma T: Effects of aerobic training and recreational activities in patients with chronic obstructive pulmonary disease. Int J Rehabil Res 2008; 31: 275–83. CrossRef MEDLINE
e31.Keating D, Levvey B, Kotsimbos T, et al.: Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years. Transplant Proc 2009; 41: 289–91. CrossRef MEDLINE
e32.Wille KM, Harrington KF, deAndrade JA, Vishin S, Oster RA, Kaslow RA: Disparities in lung transplantation before and after introduction of the lung allocation score. J Heart Lung Transplant 2013; 32: 684–92. CrossRef MEDLINE
e33.McShane PJ, Garrity ER Jr: Impact of the lung allocation score. Semin Respir Crit Care Med 2013; 34: 275–80. CrossRef MEDLINE
e34.Smits JM, Nossent GD, de Vries E, et al.: Evaluation of the lung allocation score in highly urgent and urgent lung transplant candidates in Eurotransplant. J Heart Lung Transplant 2011; 30: 22–8. CrossRef MEDLINE
e35.Sommer W, Kühn C, Tudorache I, et al.: Extended criteria donor lungs and clinical outcome: Results of an alternative allocation algorithm. J Heart Lung Transplant 2013; 32: 1065–72. CrossRef MEDLINE
e36.Pêgo-Fernandes PM, Samano MN, Fiorelli AI, et al.: Recommendations for the use of extended criteria donors in lung transplantation. Transplant Proc 2011; 43: 216–9. CrossRef MEDLINE
e37.Smits JM, van der Bij W, Van Raemdonck D, et al.: Defining an extended criteria donor lung: an empirical approach based on the Eurotransplant experience. Transpl Int 2011; 24: 393–400. CrossRef MEDLINE
e38.Meers C, van Raemdonck D, Verleden GM, et al.: The number of lung transplants can be safely doubled using extended criteria donors; a single-center review. Transpl Int 2010; 23: 628–35. CrossRef MEDLINE
e39.Machuca TN, Schio SM, Camargo SM, et al.: Prognostic factors in lung transplantation: the Santa Casa de Porto Alegre experience. Transplantation 2011; 91: 1297–303. CrossRef MEDLINE
e40.Fitzsullivan E, Gries CJ, Phelan P, et al.: Reduction in airway complications after lung transplantation with novel anastomotic technique. Ann Thorac Surg 2011; 92: 309–15. CrossRef MEDLINE PubMed Central
e41.Murthy SC, Gildea TR, Machuzak MS: Anastomotic airway complications after lung transplantation. Curr Opin Organ Transplant 2010; 15: 582–7. CrossRef MEDLINE
e42.Iga N, Oto T, Okada M, et al.: Detection of airway ischaemic damage after lung transplantation by using autofluorescence imaging bronchoscopy. Eur J Cardiothorac Surg 2013 (epub ahead of print) MEDLINE
e43.Samano MN, Minamoto H, Junqueira JJ, et al.: Bronchial complications following lung transplantation. Transplant Proc 2009; 41: 921–6. CrossRef MEDLINE
e44.Weder W, Inci I, Korom S, et al.: Airway complications after lung transplantation: risk factors, prevention and outcome. Eur J Cardiothorac Surg 2009; 35: 293–8. CrossRef MEDLINE
e45.Moreno P, Alvarez A, Algar FJ, et al.: Incidence, management and clinical outcomes of patients with airway complications following lung transplantation. Eur J Cardiothorac Surg 2008; 34: 1198–205. CrossRef MEDLINE
e46.Pettersson GB, Karam K, Thuita L, et al.: Comparative study of bronchial artery revascularization in lung transplantation. J Thorac Cardiovasc Surg 2013; 146: 894–900. CrossRef MEDLINE
e47.Pettersson GB, Yun JJ, Nørgaard MA: Bronchial artery revascularization in lung transplantation: techniques, experience, and outcomes. Curr Opin Organ Transplant 2010; 15: 572–7. CrossRef MEDLINE
e48.Witt CA, Hachem RR: Immunosuppression: what’s standard and what’s new? Semin Respir Crit Care Med 2013; 34: 405–13. CrossRef MEDLINE
e49.Treede H, Glanville AR, Klepetko W, et al.: European and Australian investigators in lung transplantation. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation. J Heart Lung Transplant 2012; 31: 797–804. CrossRef MEDLINE
e50.Benden C, Danziger-Isakov L, Faro A: New developments in treatment after lung transplantation. Curr Pharm Des 2012; 18: 737–46. CrossRef MEDLINE
e51.Bosma OH, Vermeulen KM, Verschuuren EA, Erasmus ME, van der Bij W: Adherence to immunosuppression in adult lung transplant recipients: prevalence and risk factors. J Heart Lung Transplant 2011; 30: 1275–80. CrossRef MEDLINE
e52.Peddi VR, Wiseman A, Chavin K, Slakey D: Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation. Transplant Rev 2013; 27: 97–107. CrossRef MEDLINE
e53.von Suesskind-Schwendi M, Brunner E, Hirt SW, et al.: Suppression of bronchiolitis obliterans in allogeneic rat lung transplantation-effectiveness of everolimus. Exp Toxicol Pathol 2013; 65: 383–9. CrossRef MEDLINE
e54.Säemann MD, Haidinger M, Hecking M, Hörl WH, Weichhart T: The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 2009; 9: 2655–61. CrossRef MEDLINE
e55.Verleden SE, Vandermeulen E, Ruttens D, et al.: Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS). Semin Respir Crit Care Med 2013; 34: 352–60. CrossRef MEDLINE
e56.Wiita AP, Roubinian N, Khan Y, et al.: Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis. Transpl Infect Dis 2012; 14: 248–58. CrossRef MEDLINE
e57.Patel N, Snyder LD, Finlen-Copeland A, Palmer SM: Is prevention the best treatment? CMV after lung transplantation. Am J Transplant 2012; 12: 539–44. CrossRef MEDLINE
e58. Zamora MR, Budev M, Rolfe M, et al.: RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 2011; 183: 531–8. CrossRef MEDLINE
e59.Lease ED, Zaas DW: Update on infectious complications following lung transplantation. Curr Opin Pulm Med 2011; 17: 206–9. CrossRef MEDLINE
e60. Bridevaux PO, Aubert JD, Soccal PM, et al.: Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax 2014; 69: 32–8. CrossRef MEDLINE
e61.Diez Martinez P, Pakkal M, Prenovault J, et al.: Postoperative imaging after lung transplantation. Clin Imaging 2013; 37: 617–23. CrossRef MEDLINE
e62.Patel JK, Kobashigawa JA: Thoracic organ transplantation: laboratory methods. Methods Mol Biol 2013; 1034: 127–43. CrossRef MEDLINE
e63.Nakajima T, Palchevsky V, Perkins DL, Belperio JA, Finn PW: Lung transplantation: infection, inflammation, and the microbiome. Semin Immunopathol 2011; 33: 135–56. CrossRef MEDLINE
e64. Verleden GM, Vos R, Verleden SE, et al.: Survival determinants in lung transplant patients with chronic allograft dysfunction. Transplantation 2011; 92: 703–8. CrossRef MEDLINE
e65.Lease ED, Zaas DW: Complex bacterial infections pre- and posttransplant. Semin Respir Crit Care Med 2010; 31: 234–42. CrossRef CrossRef
e66.Sengpiel J, Fuehner T, Kugler C, et al.: Use of telehealth technology for home spirometry after lung transplantation: a randomized controlled trial. Prog Transplant 2010; 20: 310–7. MEDLINE
e67.Verleden GM, Vos R, De Vleeschauwer SI, et al.: Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transpl Int 2009; 22: 771–9. CrossRef MEDLINE
e68.Dauriat G, Mal H, Thabut G, et al.: Lung transplantation for pulmonary langerhans’ cell histiocytosis: a multicenter analysis. Transplantation 2006; 81: 746–50. CrossRef MEDLINE
e69.Benden C, Rea F, Behr J, et al.: Lung transplantation for
lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant 2009; 28: 1–7. CrossRef MEDLINE
e70.Hayes D Jr, Galantowicz M, Yates AR, Preston TJ, Mansour HM, McConnell PI: Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction. J Artif Organs 2013; 16: 382–5. CrossRef MEDLINE
e71.Shah RJ, Diamond JM, Cantu E, et al.: Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest 2013; 144: 616–22. CrossRef MEDLINE
e72.Diamond JM, Lee JC, Kawut SM, et al.: Lung Transplant Outcomes Group. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187: 527–34. CrossRef MEDLINE
e73.Dawson KL, Parulekar A, Seethamraju H: Treatment of
hyperacute antibody-mediated lung allograft rejection with eculizumab. J Heart Lung Transplant 2012; 31: 1325–6. CrossRef MEDLINE
e74.Martinu T, Howell DN, Palmer SM: Acute cellular rejection and humoral sensitization in lung transplant recipients. Semin Respir Crit Care Med 2010; 31: 179–88. CrossRef MEDLINE
e75.Weigt SS, DerHovanessian A, Wallace WD, Lynch JP 3rd, Belperio JA: Bronchiolitis obliterans syndrome: the Achilles’ heel of lung transplantation. Semin Respir Crit Care Med 2013; 34: 336–51. CrossRef MEDLINE
e76.Atanasova S, Hirschburger M, Jonigk D, et al.: A relevant experimental model for human bronchiolitis obliterans syndrome. J Heart Lung Transplant 2013 ; 32: 1131–9. CrossRef MEDLINE
e77.Suzuki H, Lasbury ME, Fan L, et al.: Role of complement activation in obliterative bronchiolitis post-lung transplantation. J Immunol 2013; 191: 4431–9. CrossRef MEDLINE
e78.Sato M, Ohmori-Matsuda K, Saito T, et al.: Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 2013; 32: 484–91. CrossRef MEDLINE
e79.McManigle W, Pavlisko EN, Martinu T: Acute cellular and antibody-mediated allograft rejection. Semin Respir Crit Care Med 2013; 34: 320–35. CrossRef MEDLINE
e80.Mihalek AD, Rosas IO, Padera RF Jr, et al.: Interstitial pneumonitis and the risk of chronic allograft rejection in lung transplant recipients. Chest 2013; 143: 1430–5. CrossRef MEDLINE
e81.Verleden SE, Ruttens D, Vandermeulen E, et al.: Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? Transplantation 2013; 95: 1167–72. MEDLINE
e82.Martinu T, Chen DF, Palmer SM: Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009; 6: 54–65. CrossRef MEDLINE PubMed Central
e83.Mason DP, Rajeswaran J, Li L, et al.: Effect of changes in postoperative spirometry on survival after lung transplantation. J Thorac Cardiovasc Surg 2012; 144: 197–203. CrossRef MEDLINE
e84.Husain S, Resende MR, Rajwans N, et al.: Elevated CXCL10 (IP-10) in bronchoalveolar lavage fluid is associated with acute cellular rejection after human lung transplantation. Transplantation 2013; 97: 90–7. CrossRef MEDLINE
e85.Krustrup D, Madsen CB, Iversen M, Engelholm L, Ryder LP, Andersen CB: The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection. Transpl Immunol 2013; 29: 71–5. CrossRef MEDLINE
e86.Schlischewsky E, Fuehner T, Warnecke G, et al.: Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients. Transpl Infect Dis 2013; 15: 60–9. CrossRef MEDLINE
e87.Sandrini A, Glanville AR: The controversial role of surveillance bronchoscopy after lung transplantation. Curr Opin Organ Transplant 2009; 14: 494–8. CrossRef MEDLINE
e88.Thompson ML, Flynn JD, Clifford TM: Pharmacotherapy of lung transplantation: an overview. J Pharm Pract 2013; 26: 5–13. CrossRef MEDLINE
e89.Sweet SC: Induction therapy in lung transplantation. Transpl Int 2013; 26: 696–703. CrossRef MEDLINE
e90.Paraskeva M, McLean C, Ellis S, et al.: Acute fibrinoid organizing pneumonia after lung transplantation. Am J Respir Crit Care Med 2013; 187: 1360–8. CrossRef MEDLINE
e91.Shields RK, Clancy CJ, Minces LR, et al.: Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes. J Heart Lung Transplant 2012; 31: 1199–206. CrossRef MEDLINE
e92.Verleden GM, Vos R, van Raemdonck D, Vanaudenaerde B: Pulmonary infection defense after lung transplantation: does airway ischemia play a role? Curr Opin Organ Transplant 2010; 15: 568–71. CrossRef MEDLINE
e93.Prado e Silva M, Soto SF, Almeida FM, et al.: Immunosuppression effects on airway mucociliary clearance: comparison between two triple therapies. Ann Thorac Surg 2013; 96: 473–7. CrossRef MEDLINE
e94.Aaron SD, Vandemheen KL, Ramotar K, et al.: Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 2010; 304: 2145–53. CrossRef CrossRef
e95.De Soyza A, Meachery G, Hester KL, et al.: Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J Heart Lung Transplant 2010; 29: 1395–404. CrossRef MEDLINE
e96.Hafkin J, Blumberg E: Infections in lung transplantation: new insights. Curr Opin Organ Transplant 2009; 14: 483–7. CrossRef MEDLINE
e97.Nicolls MR, Zamora MR: Bronchial blood supply after lung transplantation without bronchial artery revascularization. Curr Opin Organ Transplant 2010; 15: 563–7. CrossRef MEDLINE
e98.Lund LH, Edwards LB, Kucheryavaya AY, et al.: International Society for Heart and Lung Transplantation. The registry of the international society for heart and lung transplantation: thirtieth official adult heart transplant report-2013; focus theme: age. J Heart Lung Transplant 2013; 32: 951–64. CrossRef MEDLINE
e99.Ahmad S, Shlobin OA, Nathan SD: Pulmonary complications of lung transplantation. Chest 2011; 139: 402–11. CrossRef MEDLINE
e100. Shofer SL, Wahidi MM, Davis WA, et al.: Significance of and risk factors for the development of central airway stenosis after lung transplantation. Am J Transplant 2013; 13: 383–9. CrossRef MEDLINE
e101. Castleberry AW, Worni M, Kuchibhatla M, et al.: A comparative analysis of bronchial stricture after lung transplantation in recipients with and without early acute rejection. Ann Thorac Surg 2013; 96: 1008–18. CrossRef MEDLINE
e102. Barnard JB, Davies O, Curry P, et al.: Size matching in lung transplantation: An evidence-based review. J Heart Lung Transplant 2013; 32: 849–60. CrossRef MEDLINE
e103. Eberlein M, Reed RM, Bolukbas S, et al.: Lung size mismatch and survival after single and bilateral lung transplantation. Ann Thorac Surg 2013; 96: 457–63. CrossRef MEDLINE
e104. Santacruz JF, Mehta AC: Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc 2009; 6: 79–93. CrossRef MEDLINE
e105. Fuehner T, Suhling H, Greer M, et al.: Biodegradable stents after lung transplantation. Transpl Int 2013; 26: e58–60. MEDLINE
e106.Paradela de la Morena M, De La Torre Bravos M, Prado RF, et al.: Chronic kidney disease after lung transplantation: incidence, risk factors, and treatment. Transplant Proc 2010; 42: 3217–9. CrossRef MEDLINE
e107. See VY, Roberts-Thomson KC, Stevenson WG, Camp PC, Koplan BA: Atrial arrhythmias after lung transplantation: epidemiology, mechanisms at electrophysiology study, and outcomes. Circ Arrhythm Electrophysiol 2009; 2: 504–10. CrossRef MEDLINE
e108.Hall EC, Pfeiffer RM, Segev DL, Engels EA: Cumulative incidence of cancer after solid organ transplantation. Cancer 2013; 119: 2300–8. CrossRef MEDLINE
e109.Neuringer IP: Posttransplant lymphoproliferative disease after lung transplantation. Clin Dev Immunol 2013; 2013: 430209. MEDLINE
e110.Bhaskaran A, Hosseini-Moghaddam SM, Rotstein C, Husain S: Mold infections in lung transplant recipients. Semin Respir Crit Care Med 2013; 34: 371–9. CrossRef MEDLINE
e111. Singer J, Yelin EH, Katz PP, et al.: Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev 2011; 31: 111–9. CrossRef MEDLINE PubMed Central
e112. Wickerson L, Mathur S, Brooks D: Exercise training after lung transplantation: a systematic review. J Heart Lung Transplant 2010; 29: 497–503. CrossRef MEDLINE
e113. Ihle F, Neurohr C, Huppmann P, et al.: Munich Lung Transplant Group. Effect of inpatient rehabilitation on quality of life and exercise capacity in long-term lung transplant survivors: A prospective, randomized study. J Heart Lung Transplant 2011; 30: 912–9. MEDLINE
e114.Suissa S, Dell’Aniello S, Ernst P: Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67: 957–63. CrossRef MEDLINE PubMed Central
e115. Shigemura N, Sclabassi RJ, Bhama JK, et al.: Early major neurologic complications after lung transplantation: incidence, risk factors, and outcome. Transplantation 2013; 95: 866–71. CrossRef MEDLINE
e116.Yusen RD: Survival and quality of life of patients undergoing lung transplant. Clin Chest Med 2011; 32: 253–64. CrossRef MEDLINE